Extended-release exenatide (Bydureon BCise) has an apparent terminal half-life of approximately 2 weeks due to its depot formulation, with drug concentrations potentially persisting for 8-10 weeks after discontinuation
If you have any doubts about whether the medication has been stored properly, contact the pharmacy or your healthcare provider for advice
Using activity-based probes coupled with mass spectrometry and biochemical validation, we found that the average DUB activity is reduced by approximately 40% in old brains due to increased cysteine oxidation, and it can be restored by antioxidant treatments both in vitro and in vivo
DutourAAbdesselamIAncelPKoberFMradGDarmonPet alExenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy
ERAD helps mitigate this burden by degrading these proteins, thereby preventing their aggregation and the subsequent activation of detrimental pathways, such as chronic ER stress, autophagy dysfunction, and apoptotic signaling
